New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa. No therapy exists for this rare inherited disease ...

Get Instant Summarized Text (Gist) Reserpine, a drug initially approved for high blood pressure, shows potential in preventing vision loss in retinitis pigmentosa, a rare inherited blinding ...

Reserpine's neuroprotective effect is independent of any specific underlying gene mutation," said the study's lead investigator, Anand Swaroop, Ph.D., senior investigator at NIH's National Eye ...

It's been nearly 20 years since Tom Cruise 's infamous outburst on the Today show, where he passionately railed against antidepressants and called psychiatry a 'pseudoscience.' ...

If patients did not meet the BP goal with the maximum tolerated dose of the initial medication, an open-label step 2 agent (atenolol, 25-100 mg/day; reserpine, 0.05-0.2 mg/day; or clonidine ...

Version of Record: This is the final version of the article. The authors investigate the neuroprotective effect of reserpine in a retinitis pigmentosa (P23H-1) model, characterized by a mutation in ...

Researchers at the National Institutes of Health (NIH) have found that reserpine, a drug no longer used for blood pressure due to side effects, may help protect vision in people with retinitis ...

This important Research Advance presents convincing evidence on the neuroprotective effects of reserpine in a well-established model of retinitis pigmentosa (P23H-1). This study builds on previous ...

How a trio of "tranquilizing" substances- chlorpromazine, reserpine and Frenquel—have opened up a new approach to investigation of the biochemistry of mental illness ...